Comparative in vitro activities of SCE-129, sulbenicillin, gentamicin, and dibekacin against Pseudomonas.
AUTOR(ES)
Tsuchiya, K
RESUMO
Against sulbenicillin- and gentamicin-susceptible strains of Pseudomonas aeruginosa, SCE-129 was about 10 times more active than sulbenicillin and had a similar activity to gentamicin and dibekacin. Sulbenicillin-resistant strains of P. aeruginosa were moderately resistant to SCE-129, whether these strains were gentamicin-resistant or not. Gentamicin-resistant strains of P. aeruginosa were resistant to dibekacin but not to SCE-129. Against P. maltophilia, the minimum inhibitory concentration of SCE-129 resembled those of sulbenicillin, gentamicin, and dibekacin. Most strains of P. cepacia were moderately resistant to SCE-129 and sulbenicillin and highly resistant to gentamicin and dibekacin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352277Documentos Relacionados
- Comparative In Vivo Activities of Cefsulodin, Sulbenicillin, and Gentamicin Against Pseudomonas aeruginosa
- SCE-129, Antipseudomonal Cephalosporin: In Vitro and In Vivo Antibacterial Activities
- SCE-129, Antipseudomonal Cephalosporin: In Vitro and In Vivo Antibacterial Activities
- In Vitro Comparison of Kanamycin, Kanendomycin, Gentamicin, Amikacin, Sisomicin, and Dibekacin Against 200 Strains of Pseudomonas aeruginosa
- In Vitro Antibacterial Activity and β-Lactamase Stability of SCE-129, a New Cephalosporin
